To read the full version of this content please select one of the options below:

The emerging cannabis treatment population

Ian Hamilton (Lecturer, based at Health Sciences, University of York, York, UK)
Charlie Lloyd (Senior Researcher, based at Health Sciences, University of York, York, UK)
Mark Monaghan (Lecturer, based at Sociology and Social Policy, University of Leeds, Leeds, UK)
Kirsteen Paton (Lecturer, based at Sociology and Social Policy, University of Leeds, Leeds, UK)

Drugs and Alcohol Today

ISSN: 1745-9265

Article publication date: 26 August 2014

Downloads
473

Abstract

Purpose

The purpose of this paper is to examine recent trends in presentation to treatment where cannabis is identified as the primary drug.

Design/methodology/approach

Data is drawn from the recently published Public Health England report and supplemented with Home Office and European data.

Findings

The data shows a marked increase in presentations for cannabis treatment over recent years. The authors offer some potential explanations for this trend.

Research limitations/implications

The authors need to improve our understanding of the type of cannabis that is available and how specifically it is used. In parallel there is a pressing need for an evaluation of evidence in relation to treatment for problematic cannabis users.

Originality/value

This paper highlights this recent trend in treatment presentations, offers some potential explanations and makes associated recommendations.

Keywords

Citation

Hamilton, I., Lloyd, C., Monaghan, M. and Paton, K. (2014), "The emerging cannabis treatment population", Drugs and Alcohol Today, Vol. 14 No. 3, pp. 150-153. https://doi.org/10.1108/DAT-01-2014-0005

Publisher

:

Emerald Group Publishing Limited

Copyright © 2014, Emerald Group Publishing Limited